Clinical Trial

The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study

Study acronym: HOPE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, observational study which is evaluating the obstetrical, neonatal, and cardiovascular outcomes of 1000 pregnant people with known heart disease to define how best to structure cardio-obstetrics care to optimize outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-23.
Status change: Not Yet Recruiting → Recruiting 2025-01-16
Trial Details
NCT Number NCT06517628
Lead Sponsor University of Missouri, Kansas City
Collaborators: Albert Einstein College of Medicine, Baylor College of Medicine, Beth Israel Deaconess Medical Center, The Children's Hospital Corporation, The Brigham and Women's Hospital, Inc., Columbia University, Henry Ford Hospital, The Johns Hopkins University, The Miriam Hospital/Lifespan, The General Hospital Corporation d/b/a Massachusetts General Hospital, Northwell Health, Northwestern University, Oregon Health and Science University, Saint Luke's Health System Inc., Board of Trustees of the Leland Stanford Junior University, The Research Foundation for the State University of New York, The Regents of the University of California, Irvine, The Regents of the University of California, Los Angeles, University of North Carolina, Chapel Hill, The Board of Trustees of the University of Illinois, Trustees of Indiana University, University of Kansas Medical Center, University of Massachusetts, Worcester, Regents of the University of Michigan, University of Mississippi Medical Center, The Curators of the University of Missouri, The Trustees of the University of Pennsylvania, University of Pittsburgh, University of South Florida, University of Washington, University of Texas Southwestern Medical Center, Weil Medical Colleqe of Cornell University, Women and Infants Hospital of Rhode Island, Tennessee Maternal Fetal Medicine PLC
Conditions Pregnancy Complications, Cardiovascular
Enrollment 1,000 participants
Start Date 2025-01-14
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-20